Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2,490,642
-
Shares change
-
-1,043,841
-
Total reported value, excl. options
-
$10,025,330
-
Value change
-
-$5,545,456
-
Put/Call ratio
-
2.18%
-
Number of buys
-
12
-
Number of sells
-
-10
-
Price
-
$4.02
Significant Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q3 2021
39 filings reported holding CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock as of Q3 2021.
CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,490,642 shares
of 45,782,552 outstanding shares and own 5.44% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (968,081 shares), BlackRock Inc. (300,201 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (238,365 shares), GEODE CAPITAL MANAGEMENT, LLC (205,572 shares), CITADEL ADVISORS LLC (111,550 shares), NORTHERN TRUST CORP (104,672 shares), GSA CAPITAL PARTNERS LLP (96,632 shares), Bank of New York Mellon Corp (85,375 shares), STATE STREET CORP (71,748 shares), and Virtu Financial LLC (55,200 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.